Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
University of Augsburg has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This case is handled by 1 distinct examiner, DENT, ALANA HARRIS, within 1 distinct art unit. DENT, ALANA HARRIS is the busiest examiner with 1 pending action, covering the university's entire active prosecution in this field. The portfolio's current activity is concentrated under this single official, which can simplify the communication process between the university and the office.
The concentration of the 1 pending office action within 1 distinct art unit allows the applicant to focus their technical arguments on the specific standards of that group. Because DENT, ALANA HARRIS is the only official involved, practitioners should prioritize understanding this 1 distinct examiner's past decisions and preferred claim structures. This streamlined prosecution path reduces the need for coordinating across different technical groups but also means the university's current biotech portfolio depends entirely on the resolution of this single matter. Success will require a strategy that directly addresses the 1 distinct art unit's standards.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DENT, ALANA HARRIS | 1 | 44.1% | +32.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18165683 | METHODS OF DETECTING AND TREATING IMMUNOTHERAPY-RESISTANT CANCER | DENT, ALANA HARRIS | 32d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18165683 | METHODS OF DETECTING AND TREATING IMMUNOTHERAPY-RESISTANT CANCER | DENT, ALANA HARRIS | 32d overdue |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18165683 | METHODS OF DETECTING AND TREATING IMMUNOTHERAPY-RESISTANT CANCER | DENT, ALANA HARRIS | 1643 | §103§112 | Final Rejection | 32d overdue | Pending | Feb 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Augsburg has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Alana Harris Dent has the most, with 1 of University of Augsburg's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.